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Autosomal recessive retinitis 
pigmentosa with homozygous 
rhodopsin mutation E150K and 
non-coding cis-regulatory variants 
in CRX-binding regions of SAMD7
Kristof Van Schil1, Marcus Karlstetter2, Alexander Aslanidis2, Katharina Dannhausen2, 
Maleeha Azam3, Raheel Qamar3,4,5, Bart P. Leroy1,6,7, Fanny Depasse8, Thomas Langmann2 & 
Elfride De Baere1
The aim of this study was to unravel the molecular pathogenesis of an unusual retinitis pigmentosa 
(RP) phenotype observed in a Turkish consanguineous family. Homozygosity mapping revealed two 
candidate genes, SAMD7 and RHO. A homozygous RHO mutation c.448G > A, p.E150K was found in 
two affected siblings, while no coding SAMD7 mutations were identified. Interestingly, four non-coding 
homozygous variants were found in two SAMD7 genomic regions relevant for binding of the retinal 
transcription factor CRX (CRX-bound regions, CBRs) in these affected siblings. Three variants are located 
in a promoter CBR termed CBR1, while the fourth is located more downstream in CBR2. Transcriptional 
activity of these variants was assessed by luciferase assays and electroporation of mouse retinal 
explants with reporter constructs of wild-type and variant SAMD7 CBRs. The combined CBR2/CBR1 
variant construct showed significantly decreased SAMD7 reporter activity compared to the wild-type 
sequence, suggesting a cis-regulatory effect on SAMD7 expression. As Samd7 is a recently identified 
Crx-regulated transcriptional repressor in retina, we hypothesize that these SAMD7 variants might 
contribute to the retinal phenotype observed here, characterized by unusual, recognizable pigment 
deposits, differing from the classic spicular intraretinal pigmentation observed in other individuals 
homozygous for p.E150K, and typically associated with RP in general.
Inherited retinal dystrophies (RDs) affect millions of individuals worldwide. Retinitis pigmentosa (RP, 
MIM[268000]) is the most prevalent form of RD, with a prevalence of 1 in 4000 and accounting for approximately 
half of the RD cases. It is a progressive disease that typically presents with degeneration of the rod photoreceptors, 
followed by loss of cone photoreceptor function. Most patients experience night blindness as an initial symptom. 
Subsequently, a gradual constriction of the peripheral visual field occurs, often followed by loss of central vision. 
However, the clinical presentation of RP is highly variable, which is also reflected in an impressive genetic heter-
ogeneity. Inheritance can be autosomal dominant (30–40% of cases), autosomal recessive (50–60%) or X-linked 
(5–15%)1,2. More than 70 disease causing genes have been associated with the molecular pathogenesis of RP 
today, most of which account for only a small percentage of cases3. One exception is the rhodopsin (RHO) gene, 
accounting for 30–40% of autosomal dominant RP (adRP) in the North American population3,4. In contrast to the 
numerous mutations with an autosomal dominant (AD) inheritance described in this gene, only a few recessive 
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mutations have been reported so far5–10. Rhodopsin, which is a photosensitive molecule located in the mem-
branes of the outer segments of rod photoreceptors, consists of a rod-specific opsin bound to the chromophore 
11-cis-retinal. After absorption of a photon, this chromophore undergoes a conformational change, triggering the 
phototransduction cascade, converting light into electrical signals11.
Despite the large number of RP disease genes that already have been identified, still 40–50% of patients remain 
without molecular genetic diagnosis1. Some of these patients are assumed to have a mutation in a novel, yet to 
be identified disease gene. The current emergence of whole exome/genome sequencing (WES/WGS) studies in 
RDs greatly facilitates in identifying these genes12–16. However, analysis of WES and WGS data is still challeng-
ing and additional filtering strategies are needed. One strategy that has been shown to be effective is the use of 
a Crx-based cis-regulatory dataset13,17,18. This dataset consists of a genome-wide map of binding regions of the 
key retinal transcription factor Crx thereby identifying genes that are specifically regulated by this transcription 
factor17. One of these genes is Samd7 (sterile alpha motif domain containing 7), which is highly expressed in the 
adult murine retina and localizes to the outer nuclear layer of the retina, containing the photoreceptor nuclei17,19. 
It has been suggested that this gene encodes a transcriptional repressor, involved in fine-tuning of Crx-regulated 
gene expression19. Although this is an excellent candidate RD disease gene, no SAMD7 mutations have been 
reported in humans so far.
Besides patients with coding mutations in novel disease genes, other patients remaining without molecular 
genetic diagnosis could have a yet unidentified mutation in already known RD disease genes, albeit located in 
functional elements outside the protein coding part of the gene. Examples are mutations in the 5′ untranslated 
region (UTR), the core promoter of the gene, the 3′ UTR containing microRNA binding sites, deep intronic 
regions influencing splicing or in more distant regulatory elements such as enhancers20–24. Several examples of 
non-coding mutations in such elements have been reported in RD, including a deletion of the first non-coding 
exon of EYS25, LCA526 and PCDH1527 containing the promoter of the gene; a non-coding mutation in the first 
non-coding exon of EYS25; mutations in the 5′ untranslated region of NMNAT128, deep intronic variants in the 
ABCA429–31, OFD132, CEP29033, USH2A34 and PROM135 genes leading to alternate splicing; and a mutation in 
the seed region of microRNA-20436, and very recently variations in a DNase I hypersensitivity site upstream of 
PRDM1337.
Here, we report on the molecular pathogenesis in a Turkish consanguineous autosomal recessive RP (arRP) 
family with unusual nummular retinal pigmentation. The RHO mutation E150K was found in a homozygous 
state in the affected individuals as well as homozygous non-coding SNPs of SAMD7. Specifically, these variants 
were found in non-coding CRX-bound regions (CBRs) associated with the SAMD7 gene. Luciferase experiments 
and electroporation assays in mouse retinal explants revealed an effect of these variants on SAMD7 expression, 
possibly contributing to the phenotype observed in this family.
Results
Clinical evaluation. Six family members of a Turkish consanguineous family participated in this study: two 
affected siblings displaying severe RP (IV:5 and IV:8), two healthy siblings (IV:3 and IV:9) and their mother 
(III:2), and a fifth sibling (IV:6) with a minor subclinical expression of disease (Fig. 1a).
The first affected family member (IV:5), a 49 year-old male, was diagnosed at the age of 20, after previously 
suffering from night blindness. His best corrected visual acuity (BCVA) is 20/50 in the right eye (RE) and 20/100 
in the left eye (LE), with a concentric constriction of Goldmann visual fields to the central 5°. A color vision 
defect in the blue-yellow axis as well as a subcapsular cataract were observed. On fundus photography, major 
retinal atrophy was visible, with vascular attenuation and a relatively preserved macula. In the retinal periphery a 
remarkable aspect of pigmentation was seen. Apart from classic spicular intraretinal pigmentations, conglomer-
ates of grouped nummular pigment deposits were present (Fig. 2c).
The other affected sibling (IV:8), a 44 year-old female, suffers from night blindness and visual field constric-
tion since she was 15 years old. Her BCVA is 20/40 in both eyes, with a concentric constriction of the visual fields 
to less than 10°. Bilateral posterior subcapsular cataracts were also observed. Fundus imaging showed retinal 
atrophy, albeit less severe than in the other affected sibling (IV:5). As in her affected brother (IV:5), particular 
small, nummular intraretinal pigmentations were seen, although not grouped in her. In the periphery, several 
well-delineated areas of punched-out retinal atrophy were present (Fig. 2a,b).
Extensive ophthalmological examination of two additional siblings (IV:3 and IV:9) and the mother (III:2), was 
entirely normal.
The phenotype of individual IV:6, a 47-year old male, is particularly interesting. BCVA was measured at 20/30 
in the RE and 20/25 in the LE. Visual fields were normal. He claimed to suffer from night blindness, which unfor-
tunately could not be confirmed as the patient did not allow to perform a full field electroretinogram (ERG). 
Anterior segments were normal. Fundoscopy showed multiple zones of peripheral intraretinal pigmentation with 
either a spicular or nummular aspect, as well as multiple white dots, representing minor subclinical manifesta-
tions (Fig. 2d,e).
Identification of homozygous RHO mutation E150K and non-coding SAMD7 variants. To iden-
tify the underlying genetic cause of RD in this Turkish consanguineous family, homozygosity mapping was per-
formed in the affected siblings IV:5 and IV:8. This revealed several shared homozygous regions, containing the 
SAMD7 and RHO genes located on two different non-contiguous regions on chromosome 3 (Fig. 1b). Sanger 
sequencing of the coding regions of RHO in one of the affected siblings led to the identification of a rare, yet pre-
viously described missense mutation in a homozygous state: c.448G > A, p.(Glu150Lys), also known as E150K 
(Fig. 1c)6,8,10. Segregation analysis showed that this mutation is homozygously present in the affected siblings IV:5 
and IV:8 and that all other family members are heterozygous carriers (Fig. 1a).
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Figure 1. Identification of a homozygous RHO mutation and non-coding SAMD7 variants. (a) Pedigree 
of the family. Six family members participated in this study and were clinically and genetically investigated. 
The genotype of each individual for the RHO mutation is indicated in grey, while the genotype for the SAMD7 
variants is shown in black. The affected siblings IV:5 and IV:8 are homozygous for both variants, while 
all other family members are heterozygous carriers. One of these siblings IV:6 displays minor subclinical 
manifestations, more specifically pigmentary anomalies on fundus photography and subjective complaints of 
night blindness. (b) Homozygosity mapping. SNP chip analysis in the affected siblings revealed four shared 
homozygous regions, harboring the SAMD7 and the RHO genes. Both genes are located on chr. 3, but are not 
genetically linked as they are 40 Mb apart. (c) RHO mutation. Electropherogram showing the homozygous RHO 
c.448G > A, p.(Glu150Lys) identified in the affected siblings. Segregation of this mutation is depicted in Fig. 1a. 
(d) SAMD7-associated regulatory variants. UCSC genome browser view of the SAMD7 locus (http://genome.
ucsc.edu/). The horizontal blue line in the upper part of the figure represents the structure of the SAMD7 gene, 
here only showing the first non-coding exon and a part of the adjacent intron. The orange blocks indicate the 
SAMD7-associated CBRs, with CBR1 located in the promoter region and CBR2 in the first intron. The next 
track represents the PhyloP conservation scores across 100 vertebrates, showing high conservation of both 
CBRs. The electropherograms show the homozygous variants located in the CBRs identified in both affected 
siblings. Segregation analysis of these variants is represented in Fig. 1a. (e) Disruption of CRX-binding motif. 
The middle part depicts the most overrepresented motif in CBRs, as reported by Corbo et al.17 While the wt 
CBR1 sequence is very similar to this CRX-binding motif, the variants identified in this study seem to disrupt 
it completely. (f) CBR1 variation. Comparison of the wt and the variant sequences shows that the variation in 
CBR1 consists of three SNPs with MAF 1.6%: rs201841157, rs58507718 and rs57060963 leading to an insertion, 
transversion and deletion event, respectively.
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In parallel, sequencing of all coding and non-coding exons of SAMD7 did not reveal any pathogenic changes. 
However, subsequent analysis of regulatory regions of SAMD7 in one affected sibling revealed four different varia-
tions located in CBRs. Segregation analysis demonstrated that the affected siblings IV:5 and IV:8 are homozygous 
for these variants, while all other investigated family members are heterozygous carriers (Fig. 1a). SAMD7 has 
two previously functionally validated CBRs, one located in the promoter region, CBR1, and the other, CBR2, 
located in the intronic region between the first two non-coding exons of the gene17,19. The homozygous variants 
are known single nucleotide polymorphisms (SNPs), having a minor allele frequency of 1.6% according to dbSNP 
Figure 2. Fundus appearances. (a,b) Right eye of affected sibling IV:8, fundus montage images (a), periphery 
(b). Typical aspect of RP: retinal atrophy with vascular attenuation and relatively preserved macula. Note 
variation in morphology of pigment deposits: aspect of classic spicular pigmentary changes alternate with 
unusual nummular types and several well-delineated areas of punched-out retinal atrophy, as seen here in 
inferior periphery. (c) Fundus of left eye of affected sibling IV:5, periphery. Note conglomerates of grouped 
nummular intraretinal pigmentations in superotemporal periphery in IV:5. (d,e). Fundus of right eye of sibling 
IV:6 with mild subclinical expression of disease, periphery. Multiple zones of peripheral intraretinal pigment 
migration as mild expression of RP; note difference in aspect of lesions with both spicular and nummular 
pigmentations combined. (f) Fundus of the index patient of Pakistani family RP218. Classic aspect of outer 
retinal atrophy with spicular intraretinal pigmentation without the unusual and distinct grouped nummular 
pigmentation seen in the family studied here.
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(http://www.ncbi.nlm.nih.gov/projects/SNP/). Three variants (rs201841157, rs58507718 and rs57060963) are 
located in CBR1 and consist of an insertion, transversion and deletion event, possibly disrupting a CRX-binding 
sequence, while the last variant (rs73040228) was found in CBR2 (Fig. 1d–f).
For comparison, family members of two previously described Pakistani arRP families segregating the same 
E150K RHO mutation8 were investigated for the presence of the non-coding SAMD7 variants identified in this 
study. However, not surprisingly, none of these SAMD7 variants were detected in both families. In addition, 
we performed haplotype analysis of the RHO region using the flanking markers described by Azam et al. This 
revealed no differences between the disease haplotype here and the previously reported disease-associated haplo-
type of these two Pakistani families (Supplementary Fig. 1)6,8.
SAMD7 localization in human retina. Previously, Samd7 expression has been demonstrated in cross sec-
tions of the adult murine retina, showing predominant expression in the photoreceptor nuclei19. To investigate the 
retinal localization of the human SAMD7 protein, immunohistochemical analyses of human post mortem retinas 
were performed. This showed a similar expression pattern as in murine retina, with a distinctive staining pattern 
in the photoreceptor nuclei (Fig. 3a).
Assessment of the transcriptional activity of the SAMD7 variants. Cis-regulatory activity of the two 
murine wild-type (wt) CBRs associated with Samd7 has been demonstrated previously by electroporation assays 
in mouse retinal explants17,19. Here, in order to gain insights into a regulatory effect on SAMD7 transcription of 
Figure 3. Retinal immunostaining of SAMD7 and transcriptional activity of SAMD7 variants. (a) Human 
retinal SAMD7 localization. Representative fluorescent images of horizontal cross-sections of human retina 
stained with anti-SAMD7 antibody (red, 1:250). Retinal counterstaining was performed with 4′ ,6-diamidino-2-
phenylindole (DAPI) (blue). SAMD7 immunoreactivity is predominantly detected in the photoreceptor nuclei, 
located in the ONL. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner 
plexiform layer; GCL, ganglion cell layer. (b) Luciferase experiments. Luciferase assays were performed in HEK 
cells, using different SAMD7 reporter constructs. The first construct consisted of CBR1 cloned in the pGL4.10 
reporter vector containing a luciferase expressing gene without promoter. For the second construct CBR2 was 
cloned in the pGL3 promoter vector, upstream of a luciferase reporter gene and a minimal basal promoter. 
Finally, the third construct was obtained by cloning CBR2 upstream of CBR1 in the pGL4.10 vector. Two types 
of each construct were created, one containing the wt sequence of a healthy control, the other one consisting of 
the patient (pat) sequences containing the SAMD7 CBR variants. Cis-regulatory activity could be demonstrated 
for the CBR1 constructs, while for CBR2 only very little luciferase expression could be measured. In both cases, 
no significant difference in luciferase expression has been observed between patient and control. However, 
when combining CBR2 and CBR1, luciferase expression increases for the control construct, while for the patient 
construct there is a significant decrease in expression. *corresponds with p < 0.05 after a two-sample t-test.  
(c) Electroporation reporter assays in mouse retinal explants. As a confirmation for the luciferase experiments, 
electroporation assays were carried out for a CBR2/CBR1 construct in mouse retinal explants. Control and 
variant CBR2/CBR1 were cloned in a dsRed expressing vector without basal promoter and electroporated 
into isolated retinas of P0 mice. After eight days of in vitro culture, retinas were harvested, fixed and imaged, 
confirming that the combined cis-regulatory activity of CBR2/CBR1 is lost for the patient constructs.
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the SNPs found in CBR1 and CBR2, we wanted to study the cis-regulatory effect of the human SAMD7 CBRs, 
both for wt CBRs and for variant CBRs of the patients.
First, both wt and variant human CBR1 and CBR2 were cloned in a luciferase expression vector to assess the 
activity of the CBRs by luciferase assays. CBR1 is located in the proximal promoter region of SAMD7 and was 
therefore cloned immediately upstream of the luciferase reporter gene. As CBR2 is located in a more distant 
enhancer region outside the promoter, it was cloned upstream of a luciferase reporter gene carrying a minimal 
basal promoter. A third construct consisted of CBR2 cloned upstream of CBR1, in order to assay the combined 
regulatory activity of CBR2 upstream of CBR1. As depicted in Fig. 3b, no significant difference in luciferase 
expression could be demonstrated between patient and wt constructs for CBR1 and CBR2 separately. However, 
variant constructs for which CBR2 was cloned upstream of CBR1 showed a significant 8.8 times decrease in lucif-
erase activity compared to the corresponding wt constructs [wt mean = 204.77, variant mean = 23.31, p = 0.0281] 
(Fig. 3b).
To confirm these results, electroporation assays in mouse retinal explants have been performed with vectors 
containing the combined CBRs. CBR1 was cloned upstream of a dsRed reporter gene, followed by upstream clon-
ing of CBR2. Electroporation of this construct in mouse retinal explants substantiated the luciferase data. Indeed, 
the combined CBR2/CBR1 variant construct again showed a markedly decreased SAMD7 reporter activity com-
pared with the wild type CBR2/CBR1 construct (Fig. 3c).
Discussion
The aim of this study was to unravel the molecular pathogenesis of an atypical retinitis pigmentosa phenotype 
(RP) observed in a Turkish consanguineous family. Homozygosity mapping followed by candidate gene analysis 
revealed a rare missense mutation in the RHO gene, c.448G > A p.(Glu150Lys), also known as E150K, and four 
non-coding variants in retina-specific regulatory regions of the SAMD7 gene.
The E150K RHO mutation was described for the first time by Kumaramanickavel et al. in a large Indian con-
sanguineous family. The four living affected siblings were homozygous for this mutation and displayed typical RP. 
Two other siblings were heterozygous carriers and displayed no symptoms6. Azam et al. reported two additional 
Pakistani arRP families segregating the same RHO mutation in homozygous state in affected family members 
and in heterozygous state in asymptomatic individuals8. Recently, this mutation was also reported in a homozy-
gous state in affected individuals of another Pakistani family with classic RP, with no information about hete-
rozygous carriers10. Additionally, this mutation has been extensively studied by Zhang et al. in E150K knock-in 
mice. Homozygous KK mice displayed early-onset retinal degeneration, while heterozygous EK mice showed a 
delayed-onset milder retinal degeneration. Hence, the authors state that the heterozygous RHO E150K-associated 
retinopathy should rather be classified as slowly progressing adRP instead of pure arRP and encourage all human 
patients carrying this mutation heterozygously to have a follow-up monitoring of their retinal function38. So far, 
no human symptomatic heterozygous carriers of E150K have been reported in literature however.
Most RHO mutations have a dominant mode of inheritance. Only a few recessive mutations have been 
reported: apart from the E150K mutation, only three other recessive mutations have been described, two of them 
associated with subtle retinal involvement in heterozygous carriers. Rosenfeld et al. identified the first RHO muta-
tion with autosomal recessive inheritance, c.745G > T, introducing a premature stop codon, p.(Glu249*), in a RP 
patient of French-Canadian descent originating from a consanguineous marriage. Interestingly, ERGs performed 
in both parents and heterozygous siblings showed decreased light sensitivity of rod photoreceptors in heterozy-
gous carriers, although no visual field loss could be detected5. The second mutation is located in the consensus 
sequence of the splice donor site of intron 4 (c.936 + 1G > T) and presumably leads to defective splicing of the 
gene. This mutation was first reported by Rosenfeld et al. heterozygously in a healthy control individual, only 
presenting a subtle abnormality in rod function based on ERG, suggesting an autosomal recessive (AR) inher-
itance of the mutation5. Subsequently, Macke et al. and Jacobson et al. reported about an adRP family where all 
four affected family members are heterozygous for this splice site mutation. Disease manifestation varied greatly 
with age in this family, as the oldest patient had severely decreased visual acuity and undetectable ERG, while 
the youngest one had a normal fundus, visual acuity and ERG, only showing rod sensitivity loss. This led to 
the hypothesis of AD inheritance, with a delayed effect of the mutation39,40. Later, Rosenfeld et al. reported two 
additional families with a total of 25 heterozygous carriers of whom only one 45-year old has been diagnosed 
with RP during adolescence. Ophthalmological examinations in 11 of the 24 asymptomatic carriers revealed 
only subtle rod abnormalities, even in four individuals older than 65 years of age. According to the authors, these 
findings seem to exclude an AD inheritance pattern (penetrance would only be 4%), leaving the possibility of AR/
digenic inheritance due to yet unidentified mutations or the involvement of mutations in a different RD gene41. 
Finally, the mutation was identified for the first time in a homozygous state in a South African family, substanti-
ating a recessive effect of this mutation7. Finally, Kartasasmita et al. identified a homozygous nonsense mutation, 
c.482G > A [p.(Trp161*)] in two Indonesian families with arRP. Asymptomatic heterozygous family members 
were found to have a normal fundus, although a slight delay and decrease of b-wave in scotopic ERG response 
was seen9.
The family we describe here is the fifth family reported to segregate the E150K RHO mutation, where the 
affected individuals IV:5 and IV:8 are homozygous, while all other siblings are heterozygous carriers. Of note, one 
of these siblings (IV:6) displays minor subclinical manifestations, more specifically pigmentary anomalies on fun-
dus photography and subjective complaints of night blindness. However, no remarkable decrease in visual acuity 
could be objectivized. These findings are of interest in light of the delayed-onset and milder phenotype observed 
in heterozygous EK mice and the difficult genotype-phenotype correlations for the other recessively inherited 
RHO mutations described above. Interestingly, this individual is the first heterozygous carrier of the E150K muta-
tion in whom subtle pigment deposits could be detected on fundoscopy, although no fundus anomalies were seen 
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in his two heterozygous, asymptomatic sisters. Unfortunately, all family members were reluctant to undergo an 
ERG, which can be seen as a drawback of this study. Performing an ERG in the heterozygous mildly symptomatic 
and asymptomatic individuals would allow us to detect subtle decreases in light sensitivity, as seen for the other 
recessively inherited RHO mutations.
The non-coding variants identified in the SAMD7 region add another level of complexity to the 
genotype-phenotype correlation in this family. As for the RHO mutation, the affected family members IV:5 and 
IV:8 are homozygous for the four variants, while all other siblings and their mother are heterozygous carriers. This 
is the first report of human SAMD7-associated non-coding variants, for which an effect on transcriptional regula-
tion has been demonstrated by luciferase experiments and electroporation assays in retinal explants. In addition, 
we demonstrated, for the first time, immunostaining of SAMD7 in human retina. As a potential transcriptional 
repressor, involved in fine-tuning of CRX-regulated gene expression19, reduced or abolished SAMD7 expression 
could alter the expression of other RD genes. Even though the primary genetic defect has been identified in this 
family, specifically a well studied missense mutation in RHO, a modifying effect of the regulatory SAMD7 variants 
on the observed phenotype cannot be excluded. Interestingly, in addition to the spicular pattern of pigment typi-
cally seen in RP, distinct conglomerates of grouped nummular pigmentations and several well-delineated areas of 
punched-out atrophy could be observed in the two affected siblings here. Comparison of the fundus photographs 
of these Turkish patients with those of the index patient of Pakistani family RP21 segregating the E150K RHO 
mutation8, but not the SAMD7 variants, revealed a classic RP pigmentation and absence of the distinct nummu-
lar retinal pigmentation in the Pakistani patient. These phenotypic differences between patients with the same 
primary mutation might be attributed to modifying genetic factors, like the SAMD7 variants we identified in this 
study. While the same atypical, recognizable retinal pigmentation was also seen in the extreme periphery in the 
heterozygous brother, both healthy heterozygous sisters and their mother appear to have completely normal fun-
dus photographs. This means that the subtle fundus abnormalities seen in the heterozygous brother cannot only 
be explained by the RHO and SAMD7 genotypes, assuming the presence of other modifying factors.
At present, little is known about modifying genes in human RDs. While some examples have been described 
for mice and dogs42–46, the first report in humans dealt with a known AIPL1 mutation p.(Arg302Leu) identified 
as a potential modifier allele in a patient with Leber congenital amaurosis (LCA) and prominent maculopathy 
carrying two CRB1 mutations47. Later, a variant in RPGRIP1L has been associated with the development of RD in 
individuals with ciliopathies caused by mutations in other genes48; AHI1 mutations were presented as potential 
neurological modifiers of CEP290-related disease49; in addition to previous studies showing that penetrance of 
PRPF31 mutations in adRP correlates with the expression level of the remaining wt PRPF31 allele50,51, CNOT3 was 
proposed as a modifier of PRPF31 mutations in RP with incomplete penetrance52,53; and more recently it has been 
suggested that a specific NMNAT1 variant could act as a modifier in other genetic subtypes of LCA54. In this study 
we showed a potential cis-regulatory role of upstream non-coding SNPs on SAMD7 expression, which might 
contribute to the retinal phenotype observed here. Further studies are needed however to provide more evidence 
for a primary or modifying role of respectively SAMD7 coding and non-coding variation in RD pathogenesis.
In conclusion, we identified the rare missense mutation E150K in the RHO gene in a Turkish consanguine-
ous RD family, together with non-coding variants impairing cis-regulatory activity of SAMD7-associated CBRs, 
which might contribute to the phenotype observed in this family, characterized by a specific unusual pigmenta-
tion, in addition to classic RP characteristics.
Methods
Clinical evaluation. Six family members of a Turkish consanguineous arRP family participated in this 
study: five siblings (IV:3, IV:5, IV:6, IV:8 and IV:9) and their mother (III:2). All family members underwent 
an ophthalmological examination, consisting of visual acuity measurement, slit lamp examination and fundos-
copy. We completed the examination with Goldmann visual field and optical coherence tomography for the two 
affected siblings (IV:5 and IV:8) and sibling IV:6. Informed consent was obtained, and research protocols adhered 
to the tenets of the Declaration of Helsinki and were approved by the ethical committee of Ghent University 
(PA2011/022).
Molecular genetic evaluation. Identity-by-descent and homozygosity mapping. This was per-
formed in the two affected siblings by genome-wide single-nucleotide polymorphism chip analysis using the 
HumanCytoSNP-12 BeadChip platform (Illumina, San Diego, CA). Identity-by-descent regions (>1 Mb) were 
identified using PLINK software55 integrated in ViVar56. Resulting homozygous regions were ranked accord-
ing to their length and number of consecutive homozygous single-nucleotide polymorphisms, as described by 
Coppieters et al57.
Sanger sequencing of candidate genes. Primers for the coding exons of RHO (NM_000539.3), both cod-
ing and non-coding exons of SAMD7 (NM_182610.2) and the SAMD7-associated CBRs were designed using 
Primer3Plus (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi). All primer sequences can be 
found in Supplementary Table 1. Sanger sequencing was performed on an ABI3730XL genetic analyzer using the 
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA). Sequences were analyzed 
with Seqscape software (Applied Biosystems). All genomic positions are based on genome build GRCh37/hg19.
Haplotype analysis. Primers were designed for the three SNPs used in the haplotype analysis described by Azam 
et al. (rs789231, rs2855557 and rs2625961), followed by Sanger sequencing and determination of the genotype 
for each SNP in all family members of the Turkish family and the described Pakistani family RP218. Primer 
sequences and SNP details are listed in Supplementary Table 1 and 2.
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SAMD7 immunohistochemistry in human retina. Retinal samples of human donors. Retinal samples 
of human donors were obtained from the Eye Bank of the Center of Ophthalmology, University of Cologne, 
Germany. The research followed the tenets of the Declaration of Helsinki. After dissection of the anterior seg-
ment, the remaining tissue included the posterior pole. Remaining vitreous humor was removed to obtain retinal 
tissue before further processing.
Immunohistochemistry. For immunofluorescence analysis, horizontal human retinal cryo-sections were fixed 
with 4% paraformaldehyde and rinsed with PBS. Sections were then rehydrated in PBS and preincubated with 
1% dried milk in PBS and 0.01% Tween 20 to reduce nonspecific immunoreactivity. Overnight incubation with 
the primary anti-SAMD7 Q-12 antibody (sc100141, Santa Cruz Biotechnology, Dallas, TX) was performed at 
4 °C in PBS containing 2% BSA, 0.02% NaN3 and 0.1% Triton X-100. To estimate the specificity of the primary 
antibody, control stainings without primary antibody were performed in parallel. After washing in PBS, samples 
were labeled for 1 h at room temperature with the secondary anti-rabbit antibody conjugated to Alexa594 (red) 
(Dianova, Hamburg, Germany). Nuclei counter-staining was performed with 0.1 mg/ml DAPI (4′ ,6-diamidino
-2-phenylindole) in PBS (Molecular Probes, Life Technologies, Frankfurt, Germany) for 10 min at room tem-
perature. The cryo-sections were mounted with fluorescent mounting medium (Dako Cytomation, Hamburg, 
Germany) and viewed with a Zeiss Axio Imager.M2 fluorescence microscope equipped with ApoTome.2 (Carl 
Zeiss, Jena, Germany). Microscopic pictures were analyzed with ZEN software (Carl Zeiss, Jena, Germany).
Functional evaluation of SAMD7 variants. Luciferase assays. Human CBR1 and CBR2 were PCR 
amplified in a healthy control individual and one of the affected siblings, leading to a 594 bp and 694 bp ampli-
con, respectively. The primer sequences are listed in Supplementary Table 1. Using NheI and BglII restriction 
enzyme (RE) sites CBR1 was cloned in the pGL4.10 reporter vector (Promega, Madison, WI) containing the 
luciferase expressing gene luc2 without promoter. CBR2 was cloned in the pGL3 promoter vector (Promega), 
upstream of a luciferase reporter gene luc + and a SV40 promoter, using the KpnI and NheI REs. Finally, using 
the same set of RE sites CBR2 was cloned upstream of CBR1 in the pGL4.10 vector. All clones were validated 
using vector-specific and internal primers. The SAMD7 reporter vectors were co-transfected with either a 
CRX-expressing vector (pcDNA4 CRX) or a control vector (pcDNA4HisMaxA) in HEK cells. HEK cells do not 
normally drive photoreactive gene expression and will need Crx co-transfection to drive luciferase expression. 
Transfection was carried out in 12 well plates using 100 μ L of serum-free medium, 0,2 μ g of vector DNA and 3 μ L 
of TransIT®-LT1 Transfection Reagent (Mirus, Madison, WI) per vector per well. After 48 h, luciferase activity 
was measured on an Infinite F200 Pro plate reader (Tecan, Crailsheim, Germany), using 20 μ L of cell lysate and 
100 μ L of luciferase assay reagent (Promega) per well. Luciferase activity was measured as fold change compared 
to empty plasmid. All assays have been performed in three independent experiments, using three replicates in 
each experiment.
Electroporation assays. As a confirmation for the luciferase assays, electroporation assays were carried out with 
CBR2/CBR1 vectors. CBR1 was cloned in a dsRed expressing vector without basal promoter using XbaI and KpnI 
RE sites, followed by upstream cloning of CBR2 with SalI and XbaI REs. DNA cocktails containing the SAMD7 
reporter vectors and a pCAG-GFP vector as an electroporation control were electroporated in isolated retinas of 
P0 mice. After eight days of in vitro culture, retinas were harvested, fixed and imaged. The detailed protocol used 
for the electroporation assays has been described previously58.
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